AI CEOs warn Congress that AI could make bioweapon design easier, pushing for mandatory DNA and RNA screening rules.
Dow Jones Top Company Headlines at 1 PM ET: GSK to Buy Nuvalent for $10.6 Billion in Oncology Push | J.M. ... The acquisition is set to give GSK ownership of three drug candidates for lung cancer, two ...
For most investors, the race to become the world’s most valuable company feels like a contest between Nvidia (NASDAQ:NVDA | ...
A year ago, Rory McEntee kicked up a storm by suggesting AI fulfills all his agency needs. The gym brand marketer returns to ...
A year ago, Rory McEntee kicked up a storm by suggesting AI fulfills all his agency needs. The gym brand marketer returns to ...
WWDC 2026 developer tools enter hands-on mode Tuesday as Apple’s new LanguageModel protocol lets iOS apps swap Foundation ...
Tempus AI is rated a Strong Buy, leveraging a unique data moat and network effect in healthcare AI. Click here to read an ...
"We're excited that our computational approach led us to a potential combination therapy for Alzheimer's based on existing ...
Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 2:00 PM EDTCompany ParticipantsEric Lefkofsky - ...
AI Could Revolutionise Concussion Care In Sport But Risks Remain. Artificial intelligence (AI) is rapidly reshaping medicine, ...
Microsoft released a suite of fresh MAI models at Build 2026. They work fine, but they can't compete with Claude and Gemini.
Artificial intelligence (AI) is rapidly reshaping medicine, from diagnosing disease to accelerating drug discovery. Its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results